Complex generics
GenZen equally specializes in the development of complex generics—products that are often more difficult to formulate, manufacture, or evaluate than traditional generics. These include:
Sterile injectables
Inhalations
Modified-release oral formulations
Topical and transdermal systems
Drugs with complex active ingredients or delivery systems
The company’s deep understanding of formulation science, bioequivalence / clinical strategies, and quality control enables it to overcome the technical and regulatory hurdles that typically deter market entry. These high-barrier products offer reduced competition and strong market potential, aligning with GenZen’s long-term growth strategy.